Cholera

• 

  Subject Areas on Research

  • A clinical trial of oral therapy in a rural cholera-treatment center. 
  • A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. 
  • Association between earthquake events and cholera outbreaks: a cross-country 15-year longitudinal analysis. 
  • Cholera control and anti-Haitian stigma in the Dominican Republic: from migration policy to lived experience. 
  • Cholera in Haiti and other Caribbean regions, 19th century. 
  • Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. 
  • Cholera prevention with traditional and novel water treatment methods: an outbreak investigation in Fort-Dauphin, Madagascar. 
  • Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. 
  • Control of diarrhoeal diseases. 
  • Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs. 
  • Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. 
  • Diarrhea, demography and cell signaling: lessons from microbial toxins. 
  • Endemic cholera in rural Bangladesh, 1966-1980. 
  • Evaluation of a field appropriate membrane filtration method for the detection of Vibrio cholerae for the measurement of biosand filter performance in the Artibonite Valley, Haiti. 
  • Genomic correlates of variability in immune response to an oral cholera vaccine. 
  • Gut microbial succession follows acute secretory diarrhea in humans. 
  • Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. 
  • Liposome reconstitution and transport assay for recombinant transporters. 
  • Local mobile gene pools rapidly cross species boundaries to create endemicity within global Vibrio cholerae populations. 
  • Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. 
  • Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. 
  • Non-O1, non-O139 Vibrio cholerae septicemia at a tertiary care center in Beirut, Lebanon; a case report and review. 
  • Second-generation recombination-based in vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine. 
  • Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. 
  • Surgeons, plague, and leadership: A historical mantle to carry forward. 
  • The ompU Paralogue vca1008 is required for virulence of Vibrio cholerae. 
  • Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. 
  • Using private demand studies to calculate socially optimal vaccine subsidies in developing countries.